RECRUITING

Visual Remapping to Aid Reading With Field Loss

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Reading performance in patients with Central Vision Loss and age matched controls with artificial scotomas will be measured with and without different kinds of remapping of missing text to different parts of the visual field.

Official Title

Remapping the Visual Field to Aid Reading With Central Scotomas

Quick Facts

Study Start:2022-02-01
Study Completion:2024-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03848663

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:16 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 16 years or older
  2. 2. Central vision loss of at least 5 deg diameter, including the fovea, from bilateral central scotomas
  3. 3. Stable fixation (+/- 1 deg) using their PRL.
  4. 4. No cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
  5. 5. Satisfactory calibration achievable using eye tracker
  1. 1. Central vision loss of less than 5 deg diameter; scotomas that do not cover the fovea; unilateral scotomas
  2. 2. Poor fixation (worse than+/- 1 deg) using their PRL.
  3. 3. Cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
  4. 4. Satisfactory calibration not achievable using eye tracker

Contacts and Locations

Study Contact

Stephen Engel, Ph.D.
CONTACT
612-625-5571
engel@umn.edu
Gordon Legge, Ph.D.
CONTACT
legge@umn.edu

Principal Investigator

Stephen Engel, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Stephen Engel, Ph.D., PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-01
Study Completion Date2024-11-30

Study Record Updates

Study Start Date2022-02-01
Study Completion Date2024-11-30

Terms related to this study

Keywords Provided by Researchers

  • Scotoma
  • Remapping
  • Reading
  • Low vision
  • Visual aid

Additional Relevant MeSH Terms

  • Age-related Macular Degeneration